Clinical Courses and Outcomes of Patients with Chronic Obstructive Pulmonary Disease During the COVID-19 Epidemic in Hubei, China

References

• ChenN, ZhouM, DongX, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-732007143
   PubMed Web of Science ®Google Scholar
• WangD, HuB, HuC, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061. doi:10.1001/jama.2020.1585.32031570
   PubMed Web of Science ®Google Scholar
• YangY, LuQB, LiuMJ, et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv. 2020. doi:10.1101/2020.02.10.20021675.
   Google Scholar
• GuanWJ, NiZY, HuY, et al. China medical treatment expert group for COVID–19. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032.32109013
   PubMed Web of Science ®Google Scholar
• WangC, XuJ, YangL, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-929650248
   PubMed Web of Science ®Google Scholar
• VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• LiMH, FanLC, MaoB, et al. Short-term exposure to ambient fine particulate matter increases hospitalizations and mortality in COPD: a systematic review and meta-analysis. Chest. 2016;149(2):447–458. doi:10.1378/chest.15-051326111257
   PubMed Web of Science ®Google Scholar
• LiuS, ZhouY, LiuS, et al. Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: results from a cross-sectional study in China. Thorax. 2017;72(9):788–795. doi:10.1136/thoraxjnl-2016-20891027941160
   PubMed Web of Science ®Google Scholar
• WoodheadM, BlasiF, EwigS, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2005;26(6):1138–1180. doi:10.1183/09031936.05.0005570516319346
   PubMed Web of Science ®Google Scholar
• JarttiL, LangenH, Söderlund-VenermoM, et al. New respiratory viruses and the elderly. Open Respir Med J. 2011;5:61–69. doi:10.2174/187430640110501006121760867
   PubMedGoogle Scholar
• RohdeG, BorgI, ArinirU, et al. Evaluation of a real-time polymerase chain reaction for severe acute respiratory syndrome (SARS) associated coronavirus in patients with hospitalized exacerbation of COPD. Eur J Med Res. 2004;9(11):505–509.15649859
   PubMed Web of Science ®Google Scholar
• ArabiYM, ArifiAA, BalkhyHH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160:389e397. doi:10.7326/M13-248624474051
   PubMed Web of Science ®Google Scholar
• KapoorM, PringleK, KumarA, et al. Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States. Clin Infect Dis. 2014;59:1511e1518. doi:10.1093/cid/ciu63525100864
   PubMed Web of Science ®Google Scholar
• RingshausenFC, TanAYM, AllanderT, et al. Frequency and clinical relevance of human bocavirus infection in acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2009;4:111–117. doi:10.2147/COPD.S480119436697
   PubMedGoogle Scholar
• National Health Commission of the People’s Republic of China. Diagnosis and treatment of novel coronavirus infected pneumonia (trial 7th edition) [EB/OL]; 2020 Available from: http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf.
   Google Scholar
• PeirisJSM, YuenKY, OsterhausADME, StöhrK. The severe acute respiratory syndrome. N Engl J Med. 2003;349(25):2431–2441. doi:10.1056/NEJMra03249814681510
   PubMed Web of Science ®Google Scholar
• LupiaT, ScabiniS, Mornese PinnaS, Di PerriG, De RosaFG, CorcioneS. 2019 novel coronavirus (2019-nCoV) outbreak:A new challenge. J Glob Antimicrob Resist. 2020;21:22–27. doi:10.1016/j.jgar.2020.02.021.32156648
   PubMed Web of Science ®Google Scholar
• ZhouF, YuT, DuR, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-332171076
   PubMed Web of Science ®Google Scholar
• WuC, ChenX, CaiY, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934. doi:10.1001/jamainternmed.2020.0994.32167524
   PubMed Web of Science ®Google Scholar
• GrasselliG, ZangrilloA, ZanellaA, et al. COVID-19 lombardy ICU network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574. doi:10.1001/jama.2020.5394.32250385
   PubMed Web of Science ®Google Scholar
• JiZ, de Miguel-diezJ, Castro-RieraCR, et al. Differences in the outcome of patients with COPD according to body mass index. J Clin Med. 2020;9(3):710. doi:10.3390/jcm9030710
   PubMed Web of Science ®Google Scholar
• MullerovaH, MaselliDJ, LocantoreN, et al. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest. 2015;147(4):999–1007. doi:10.1378/chest.14-065525356881
   PubMed Web of Science ®Google Scholar
• WangB, LiR, LuZ, HuangY. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020;12. doi:10.18632/aging.103000.
   Google Scholar
• MemtsoudisSG, IvascuNS, PryorKO, GoldsteinPA. Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea. Br J Anaesth. 2020;125(2):e262–e263. doi:10.1016/j.bja.2020.04.07832439072
   PubMed Web of Science ®Google Scholar
• GuoY, ZhangT, WangZ, et al. Body mass index and mortality in chronic obstructive pulmonary disease: a dose-response meta-analysis. Medicine. 2016;95(28):e4225. doi:10.1097/MD.000000000000422527428228
   PubMed Web of Science ®Google Scholar
• GorbalenyaAE, BakerSC, BaricRS, de GrootRJ, DrostenC, GulyaevaAA. Severe acute respiratory syndrome-related coronavirus: the species and its viruses–a statement of the Coronavirus Study Group. bioRxiv. 2020. doi:10.1101/2020.02.07.937862.
   Google Scholar
• WangM, DuL, ZhouDH, et al. Study on the epidemiology and measures for control on severe acute respiratory syndrome in Guangzhou city [Article in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2003;24(5):353–357.12820926
   PubMedGoogle Scholar
• SeysLJM, WidagdoW, VerhammeFM, et al. DPP4, the middle east respiratory syndrome coronavirus receptor, is upregulated in lungs of smokers and chronic obstructive pulmonary disease patients. Clin Infect Dis. 2018;66(1):45–53. doi:10.1093/cid/cix74129020176
   PubMed Web of Science ®Google Scholar
• MeyerholzDK, LambertzAM, McCrayJrPB. Dipeptidyl peptidase 4 distribution in the human respiratory tract: implications for the middle east respiratory syndrome. Am J Pathol. 2016;186(1):78–86. doi:10.1016/j.ajpath.2015.09.01426597880
   PubMed Web of Science ®Google Scholar
• ZhouP, YangXL, WangXG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-732015507
   PubMed Web of Science ®Google Scholar
• LiW, MooreMJ, VasilievaN, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454. doi:10.1038/nature0214514647384
   PubMed Web of Science ®Google Scholar
• HofmannH, PyrcK, van der HoekL, GeierM, BerkhoutB, PöhlmannS. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci USA. 2005;102:7988–7993. doi:10.1073/pnas.040946510215897467
   PubMed Web of Science ®Google Scholar
• BrakeSJ, BarnsleyK, LuW, McAlindenKD, EapenMS, SohalSS. Smoking upregulates angiotensin- converting enzyme-2 receptor: a potential adhesion site for novel Coronavirus SARS-CoV-2 (Covid-19). J Clin Med. 2020;9(3):pii: E841. doi:10.3390/jcm9030841.
   PubMed Web of Science ®Google Scholar
• LeungJM, YangCX, TamA, et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J. 2020;55(5):pii: 2000688. doi:10.1183/13993003.00688-2020.
   Web of Science ®Google Scholar
• AlqahtaniJS, OyeladeT, AldhahirAM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS One. 2020;15(5):e0233147. doi:10.1371/journal.pone.023314732392262
   PubMed Web of Science ®Google Scholar
• GuanWJ, LiangWH, ZhaoY, et al. China medical treatment expert group for Covid-19. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):pii: 2000547. doi:10.1183/13993003.00547-2020.
   Web of Science ®Google Scholar